99 related articles for article (PubMed ID: 14504049)
1. Interleukin-1 receptor antagonist gene polymorphism is associated with increased risk of epithelial ovarian cancer.
Sehouli J; Mustea A; Koensgen D; Chen FC; Lichtenegger W
Ann Oncol; 2003 Oct; 14(10):1501-4. PubMed ID: 14504049
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 receptor antagonist gene polymorphism in epithelial ovarian cancer.
Sehouli J; Mustea A; Koensgen D; Lichtenegger W
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1205-8. PubMed ID: 14652282
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer.
Mustea A; Sehouli J; Könsgen D; Stengel D; Sofroni D; Lichtenegger W
Anticancer Res; 2003; 23(2A):1099-102. PubMed ID: 12820354
[TBL] [Abstract][Full Text] [Related]
4. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
Mustea A; Pirvulescu C; Könsgen D; Braicu EI; Yuan S; Sun P; Lichtenegger W; Sehouli J
Cytokine; 2008 Apr; 42(1):77-84. PubMed ID: 18329282
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of the interleukin-1 gene cluster and ovarian cancer.
Hefler LA; Ludwig E; Lebrecht A; Zeillinger R; Tong-Cacsire D; Koelbl H; Leodolter S; Tempfer CB
J Soc Gynecol Investig; 2002; 9(6):386-90. PubMed ID: 12445604
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of the IL-8 gene and the risk of ovarian cancer.
Koensgen D; Bruennert D; Ungureanu S; Sofroni D; Braicu EI; Sehouli J; Sümnig A; Delogu S; Zygmunt M; Goyal P; Evert M; Olek S; Biebler KE; Mustea A
Cytokine; 2015 Feb; 71(2):334-8. PubMed ID: 25151495
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis.
Fang XM; Schröder S; Hoeft A; Stüber F
Crit Care Med; 1999 Jul; 27(7):1330-4. PubMed ID: 10446828
[TBL] [Abstract][Full Text] [Related]
8. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm.
Aktas D; Guney I; Alikasifoglu M; Yüce K; Tuncbilek E; Ayhan A
Gynecol Oncol; 2002 Aug; 86(2):124-8. PubMed ID: 12144816
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer.
Bushley AW; Ferrell R; McDuffie K; Terada KY; Carney ME; Thompson PJ; Wilkens LR; Tung KH; Ness RB; Goodman MT
Gynecol Oncol; 2004 Dec; 95(3):672-9. PubMed ID: 15581980
[TBL] [Abstract][Full Text] [Related]
10. Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke.
Seripa D; Dobrina A; Margaglione M; Matera MG; Gravina C; Vecile E; Fazio VM
Cerebrovasc Dis; 2003; 15(4):276-81. PubMed ID: 12686792
[TBL] [Abstract][Full Text] [Related]
11. Allelic polymorphism of the interleukin-1 receptor antagonist gene in patients with acute or stable presentation of ischemic heart disease.
Manzoli A; Andreotti F; Varlotta C; Mollichelli N; Verde M; van de Greef W; Sperti G; Maseri A
Cardiologia; 1999 Sep; 44(9):825-30. PubMed ID: 10609392
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1β, Interleukin1-Ra, Interleukin-10, and tumor necrosis factor-α polymorphisms in Tunisian patients with rheumatoid arthritis.
Lagha A; Zidi S; Stayoussef M; Gazouani E; Kochkar R; Kochbati S; Almawi WY; Yacoubi-Loueslati B
Pathol Biol (Paris); 2015 Sep; 63(4-5):179-84. PubMed ID: 26003199
[TBL] [Abstract][Full Text] [Related]
13. Smoking and polymorphisms of the interleukin-1 gene cluster (IL-1alpha, IL-1beta, and IL-1RN) in patients with periodontal disease.
Meisel P; Siegemund A; Dombrowa S; Sawaf H; Fanghaenel J; Kocher T
J Periodontol; 2002 Jan; 73(1):27-32. PubMed ID: 11846196
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer.
Wenham RM; Calingaert B; Ali S; McClean K; Whitaker R; Bentley R; Lancaster JM; Schildkraut J; Marks J; Berchuck A
J Soc Gynecol Investig; 2003 Sep; 10(6):381-7. PubMed ID: 12969782
[TBL] [Abstract][Full Text] [Related]
15. The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women.
Spurdle AB; Hopper JL; Chen X; Dite GS; McCredie MR; Giles GG; Venter DJ; Southey MC; Purdie DM; Chenevix-Trench G
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1287-93. PubMed ID: 11751447
[TBL] [Abstract][Full Text] [Related]
16. Association of interleukin-23 receptor gene polymorphisms with risk of ovarian cancer.
Zhang Z; Zhou B; Zhang J; Chen Y; Lai T; Yan L; Liang A; Li Y; Wang Y; Chen Y; Zhang L; Xi MR
Cancer Genet Cytogenet; 2010 Jan; 196(2):146-52. PubMed ID: 20082850
[TBL] [Abstract][Full Text] [Related]
17. CYP17 promotor polymorphism and ovarian cancer risk.
Spurdle AB; Chen X; Abbazadegan M; Martin N; Khoo SK; Hurst T; Ward B; Webb PM; Chenevix-Trench G
Int J Cancer; 2000 May; 86(3):436-9. PubMed ID: 10760835
[TBL] [Abstract][Full Text] [Related]
18. Body mass index but not a polymorphism of the interleukin-1 receptor antagonist (IL-1 RA) gene is associated with age at natural menopause.
Riener EK; Keck C; Worda C; Hefler LA; Tempfer CB
Gynecol Obstet Invest; 2004; 58(2):117-20. PubMed ID: 15205567
[TBL] [Abstract][Full Text] [Related]
19. Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer.
Glas J; Török HP; Schneider A; Brünnler G; Kopp R; Albert ED; Stolte M; Folwaczny C
J Clin Oncol; 2004 Dec; 22(23):4746-52. PubMed ID: 15570075
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism in patients with end-stage renal failure.
Shu KH; Cheng CH; Wu MJ; Chen CH; Lee WC
Ren Fail; 2005; 27(1):53-7. PubMed ID: 15717635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
